Literature DB >> 34059753

Association of killer cell immunoglobulin-like receptors with endemic Burkitt lymphoma in Kenyan children.

Beatrice M Muriuki1,2, Catherine S Forconi3, Peter O Oluoch2,3, Jeffrey A Bailey4, Anita Ghansah5, Ann M Moormann3, John M Ong'echa6.   

Abstract

Endemic Burkitt lymphoma (eBL) is an aggressive pediatric B cell lymphoma, common in Equatorial Africa. Co-infections with Epstein-Barr virus (EBV) and Plasmodium falciparum, coupled with c-myc translocation are involved in eBL etiology. Infection-induced immune evasion mechanisms to avoid T cell cytotoxicity may increase the role of Natural killer (NK) cells in anti-tumor immunosurveillance. Killer immunoglobulin-like receptor (KIR) genes on NK cells exhibit genotypic and allelic variations and are associated with susceptibility to diseases and malignancies. However, their role in eBL pathogenesis remains undefined. This retrospective study genotyped sixteen KIR genes and compared their frequencies in eBL patients (n = 104) and healthy geographically-matched children (n = 104) using sequence-specific primers polymerase chain reaction (SSP-PCR) technique. The relationship between KIR polymorphisms with EBV loads and eBL pathogenesis was investigated. Possession of ≥ 4 activating KIRs predisposed individuals to eBL (OR = 3.340; 95% CI 1.530-7.825; p = 0.004). High EBV levels were observed in Bx haplogroup (p = 0.016) and AB genotypes (p = 0.042) relative to AA haplogroup and AA genotype respectively, in eBL patients but not in healthy controls. Our results suggest that KIR-mediated NK cell stimulation could mute EBV control, contributing to eBL pathogenesis.

Entities:  

Year:  2021        PMID: 34059753     DOI: 10.1038/s41598-021-90596-7

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  50 in total

1.  De novo expression of killer immunoglobulin-like receptors and signaling proteins regulates the cytotoxic function of CD4 T cells in acute coronary syndromes.

Authors:  Takako Nakajima; Omer Goek; Xiaoyu Zhang; Stephen L Kopecky; Robert L Frye; Jörg J Goronzy; Cornelia M Weyand
Journal:  Circ Res       Date:  2003-06-19       Impact factor: 17.367

Review 2.  Viral modulation of NK cell immunity.

Authors:  Melissa B Lodoen; Lewis L Lanier
Journal:  Nat Rev Microbiol       Date:  2005-01       Impact factor: 60.633

3.  Burkitt's lymphoma and malaria.

Authors:  G W Kafuko; D P Burkitt
Journal:  Int J Cancer       Date:  1970-07-15       Impact factor: 7.396

4.  CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells.

Authors:  R Jacobs; G Hintzen; A Kemper; K Beul; S Kempf; G Behrens; K W Sykora; R E Schmidt
Journal:  Eur J Immunol       Date:  2001-10       Impact factor: 5.532

Review 5.  The biology of human natural killer-cell subsets.

Authors:  M A Cooper; T A Fehniger; M A Caligiuri
Journal:  Trends Immunol       Date:  2001-11       Impact factor: 16.687

6.  Natural killer cell immunodeficiency in HIV disease is manifest by profoundly decreased numbers of CD16+CD56+ cells and expansion of a population of CD16dimCD56- cells with low lytic activity.

Authors:  P F Hu; L E Hultin; P Hultin; M A Hausner; K Hirji; A Jewett; B Bonavida; R Detels; J V Giorgi
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-11-01

7.  Poorly cytotoxic terminally differentiated CD56negCD16pos NK cells accumulate in Kenyan children with Burkitt lymphomas.

Authors:  Catherine S Forconi; Cormac P Cosgrove; Pryia Saikumar-Lakshmi; Christina E Nixon; Joslyn Foley; John Michael Ong'echa; Juliana A Otieno; Galit Alter; Christian Münz; Ann M Moormann
Journal:  Blood Adv       Date:  2018-05-22

Review 8.  Burkitt's lymphoma in Africa, a review of the epidemiology and etiology.

Authors:  Jackson Orem; Edward Katongole Mbidde; Bo Lambert; Silvia de Sanjose; Elisabete Weiderpass
Journal:  Afr Health Sci       Date:  2007-09       Impact factor: 0.927

Review 9.  Emerging role of Natural killer cells in oncolytic virotherapy.

Authors:  Rauf Bhat; Jean Rommelaere
Journal:  Immunotargets Ther       Date:  2015-03-31

10.  Epstein-Barr virus, malaria and endemic Burkitt lymphoma.

Authors:  Thirumalaisamy P Velavan
Journal:  EBioMedicine       Date:  2018-12-22       Impact factor: 8.143

View more
  1 in total

1.  Compromised activity of natural killer cells in diffuse large b-cell lymphoma is related to lymphoma-induced modification of their surface receptor expression.

Authors:  Tehila Azoulay; Ilana Slouzky; Michal Karmona; Margarita Filatov; Michal Hayun; Yishai Ofran; Galit Sarig; Shimrit Ringelstein-Harlev
Journal:  Cancer Immunol Immunother       Date:  2022-09-01       Impact factor: 6.630

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.